Peter Osin
YOU?
Author Swipe
View article: Supplementary Table 3 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 3 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 81K, IPA analysis and genes in the inflammatory immune response signature.
View article: Supplementary Table 5 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 5 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 46K, Prediction analysis of correlated genes.
View article: Supplementary Figure 3 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Figure 3 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 87K, Lymphocytic infiltration in tumours.
View article: Supplementary Figure 1 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR
Supplementary Figure 1 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR Open
PDF File - 1282, Digital PCR assay for HER2 on 384 well microplates.
View article: Supplementary Figure 5 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR
Supplementary Figure 5 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR Open
PDF File - 883K, Bio-informatic comparison of different reference probes.
View article: Supplementary Figure 4 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR
Supplementary Figure 4 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR Open
PDF File - 438K, HER2 : EFTUD2 copy number ratio in validation cohort.
View article: Supplementary Figure 2 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Figure 2 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
Genetic profile of ER positive primary breast cancers that 'switch' to triple negative recurrent advanced breast cancer
View article: Supplementary Methods from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR
Supplementary Methods from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR Open
PDF File - 177K, Supplementary methods, tables, and figures legends.
View article: Supplementary Figure 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Figure 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 109K, Derivation of samples for microarray analysis.
View article: Supplementary Figure 4 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Figure 4 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
NCOR expression following NF1 loss
View article: Supplementary Figure 5 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Figure 5 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
CDK4/6 inhibition partly overcomes NF1 loss in T47D cells
View article: Supplementary Table 4 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 4 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 68K, Multivariable analysis of inflammatory metagene, grade, ER H-score, baseline Ki67 and proportional change in Ki67.
View article: Data from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Data from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
Purpose:Advanced breast cancer (ABC) has not been subjected to the same degree of molecular scrutiny as early primary cancer. Breast cancer evolves with time and under the selective pressure of treatment, with the potential to acquire muta…
View article: Supplementary Figure 5 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR
Supplementary Figure 5 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR Open
PDF File - 883K, Bio-informatic comparison of different reference probes.
View article: Supplementary Tables 1-6 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Tables 1-6 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
Supplementary Table 1. Targets of The Breast NGS v1.0 capture panel. Supplementary Table 2. Gene list of NanoString nCounter{trade mark, serif} custom codeset. Supplementary Table 3. Gene list of Human Estrogen Receptor RT2 Profiler PCR Ar…
View article: Supplementary Table 3 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 3 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 81K, IPA analysis and genes in the inflammatory immune response signature.
View article: Supplementary Figure Legend from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Figure Legend from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
Supplementary Figure Legend
View article: Supplementary Table 2 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 2 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
XLSX file - 250K, Excel file of differentially expressed and correlated genes.
View article: Supplementary Figure Legend from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Figure Legend from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 65K
View article: Supplementary Figure Legend from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Figure Legend from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
Supplementary Figure Legend
View article: Supplementary Figure 5 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Figure 5 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
CDK4/6 inhibition partly overcomes NF1 loss in T47D cells
View article: Supplementary Table 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 44K, Patient demographics.
View article: Supplementary Figure 2 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR
Supplementary Figure 2 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR Open
PDF File - 832K, Example Digital PCR analysis in 384 well plate.
View article: Supplementary Figure Legend from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Figure Legend from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 65K
View article: Supplementary Table 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 44K, Patient demographics.
View article: Supplementary Figure 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Figure 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
PDF file - 109K, Derivation of samples for microarray analysis.
View article: Supplementary Figure 1 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR
Supplementary Figure 1 from Noninvasive Detection of <i>HER2</i> Amplification with Plasma DNA Digital PCR Open
PDF File - 1282, Digital PCR assay for HER2 on 384 well microplates.
View article: Supplementary Figure 3 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Figure 3 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
NCOR expression in NF1 mutated cancers
View article: Supplementary Tables 1-6 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Supplementary Tables 1-6 from Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Open
Supplementary Table 1. Targets of The Breast NGS v1.0 capture panel. Supplementary Table 2. Gene list of NanoString nCounter{trade mark, serif} custom codeset. Supplementary Table 3. Gene list of Human Estrogen Receptor RT2 Profiler PCR Ar…
View article: Supplementary Table 2 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Supplementary Table 2 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Open
XLSX file - 250K, Excel file of differentially expressed and correlated genes.